Facilitates transformational change by evaluating hundreds
of successful healthcare initiatives at patient level to calculate commissioning opportunities.
Collaboration Module
Info:
i5 Commissioning Suite is a Software as a Service (SaSS) IT platform for collaboration between
healthcare organisations that enables information management and provides insight for commissioners.
Information Management
Info:
Manages the end-to-end data receipt process for collecting information from Providers, PCTs, CCGs, GP practices, local authorities and community or voluntary services organisations and processes unstructured data.
Invoice Validation Module
Info:
Processes secondary care activity data at patient level in SUS or SLAM format and applies it against a large number of validation rules to establish, in real time, the veracity of provider invoices.
Urgent Care Modelling
Info:
Models patient flows to evaluate admission avoidance schemes, sets metrics and KPIs and performs
demand planning to identify solutions for the local health economy.
Referral Facilitation Service
Info:
i5 Health reports provide referral details on specialties and GP practices to enable
reviews for correctness by Referral Facilitators.
Risk Assessment Module
Info:
Enables a series of tasks including impact analysis and risk mitigation initiatives.
Risk Stratification Module
Info:
Based on the Combined Model that has been updated to reflect coding changes and provide clinicians with paitent level scores.
Services and Conditions
Info:
Compares hospital activity and its cost against those for similar organisations.
Bespoke Reports
Info:
Calling on its Big Data expertise, i5 Health provides a wide range of bespoke reports for decision makers throughout the NHS – ranging from Readmissions studies for CCGs through Asthma analysis for GP localities and Specialised Commissioning recommendations for NHS England to merger support for Foundation Trusts
Demand Management
Info:
Enables users to perform demographic analysis of their patients.
Medicines Management
Info:
Reports on cost, generics, prevalence benchmarking and specific drugs.